SGRY — Surgery Partners Income Statement
0.000.00%
- $2.91bn
- $8.08bn
- $3.11bn
- 54
- 73
- 33
- 53
Annual income statement for Surgery Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,860 | 2,225 | 2,539 | 2,743 | 3,114 |
Cost of Revenue | |||||
Gross Profit | 467 | 582 | 657 | 732 | 835 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,677 | 1,923 | 2,194 | 2,415 | 2,766 |
Operating Profit | 183 | 302 | 345 | 328 | 349 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -18.8 | 81.2 | 110 | 135 | 147 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.3 | 70.7 | 87 | 135 | 12.5 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -116 | -70.9 | -54.6 | -11.9 | -168 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -156 | -81.2 | -54.6 | -11.9 | -168 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.79 | -0.822 | -0.434 | 0.519 | -0.529 |